Drug profile · INN
cromolyn sodium
CROMOLYN SODIUM
cromolyn sodium (CROMOLYN SODIUM) is a unknown. Associated with Blackmores Limited. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — cromolyn sodium
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 12
- Programs
- 0
- Data quality
- 0.89
Quick answer
cromolyn sodium (CROMOLYN SODIUM) is a unknown. Associated with Blackmores Limited. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related patents
-
US 11691011
Pain-relieving apparatus
granted -
US 10897915
Method for making coffee products containing cannabis ingredients
granted -
US 10405560
Method for making coffee products containing cannabis ingredients
granted -
US 9900622
Multiple sign bit hiding within a transform unit
granted -
US 9008184
Multiple sign bit hiding within a transform unit
granted -
US 7537421
Dead spindle PTO with compliant grounding mechanism
granted -
US 7105558
Gastrin and cholecystokinin receptor lignads (iv)
granted -
US 7034048
Gastrin and cholecystokinin receptor ligands (III)
expired -
US 6878734
Gastrin and cholecystokinin receptor ligands(II)
expired -
US 6878736
Histamine H3 receptor ligands
expired -
US 6479531
Gastrin and cholecystokinin receptor ligands
expired -
US 6159994
Histamine H.sub.3 receptor ligands
expired
Frequently asked questions
What is cromolyn sodium?
cromolyn sodium (CROMOLYN SODIUM) is a unknown. Associated with Blackmores Limited. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for cromolyn sodium?
CROMOLYN SODIUM is a marketed brand name for cromolyn sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cromolyn sodium?
cromolyn sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.